Article
Failing Fast at the Forefront of Innovation for Pharma Companies
Ravi Samavedam
In this Technology Networks article, you will learn how equipment, laboratory and experimental approaches can accelerate failure so that developers adjust their approach before it’s too late.
“Licensing cleanrooms is the middle ground between the traditional options that enable companies to focus on the science while we focus on the compliance. Our clients who are building their own facility or have current facility restrictions will use our services, so the science never stops.”
- Ravi Samavedam, Chief Innovation Officer at Azzur Group
Read the full article featured on Technology Networks Drug Discovery or learn more about how Azzur's Cleanrooms on Demand™ hybrid model can help accelerate your process to "fail fast”.
Ravi Samavedam
Ravi Samavedam joined Azzur Group in 2012 and is a Biochemical Engineer with more than 20 years of experience. Prior to his appointment to Chief Innovation Officer (CINO), Ravi served as President of Azzur Cleanrooms on Demand™ and previously was a General Manager of Azzur Boston. Ravi has been a part of technical operations, quality, and validation departments at some of the world’s foremost pharmaceutical manufacturers. He is an expert in phase-appropriate cGMP implementation, process validation, supplier management, and technology transfer. Ravi is an active member of industry and peer groups, and he is a frequent speaker at industry events.
Connect On Linkedin